Skip to content
sellWeak10b5-1 plan

Catherine Corrigan sold $329k of EXPO

President & CEO at EXPONENT INC. 4,930 shares at an average of $66.82, traded Oct 15, 2025, filed Oct 16, 2025.

Warning score
5
Value
$329k
4,930 shares
Holdings after
83,429
-6% from before
From 52-week low
+3%
low $64.11, close $66.04
From 52-week high
-40%
high $110.87, as of Oct 15, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $329k at market
    +15
  • Share of holdings sold
    Sold 5.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +2.5%, 3m +9.4%, 6m +0.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

EXPOOct 9, 2026 · close 69.81
Since filing Oct 16, 2025: +4.1%SPY +19.1% · excess -14.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000851520-25-000075, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 15, 2025MOption exercise
Common Stock10b5-1
+3,226$25.41$82k85,979Oct 16, 2025
Oct 15, 2025SOpen-market sale
Common Stock10b5-1
-3,226$66.84$216k82,753Oct 16, 2025
Oct 15, 2025MOption exercise
Common Stock10b5-1
+2,380$29.05$69k85,133Oct 16, 2025
Oct 15, 2025SOpen-market sale
Common Stock10b5-1
-1,704$66.79$114k83,429Oct 16, 2025
Oct 15, 2025MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-3,226--22,578Oct 16, 2025
Oct 15, 2025MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-2,380--21,418Oct 16, 2025

Related signals

Other insiders at EXPONENT INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
10Weak
EXPObuy
EXPONENT INC
Shukri Jeries Souri
Group Vice President
$13k
184 shares
+0%
0Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
Chief Executive Officer
$113k
1,707 shares
-1%
0Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
Chief Executive Officer
$109k
1,737 shares
-1%
3Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$235k
4,119 shares
-4%
60Notable
EXPOsell 5
EXPONENT INC
Bradley A James
Group Vice President
$115k
2,000 shares
-64%
50Moderate
EXPOsell 5
EXPONENT INC
Richard Reiss
Group Vice President
$98k
1,672 shares
-42%
18Weak
EXPOsell 510b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$227k
4,194 shares
-4%
60Notable
EXPOsell 5
EXPONENT INC
Joseph Sala
Group Vice President
$117k
2,066 shares
-100%
61Notable
EXPOsell 5
EXPONENT INC
Joseph Rakow
Group Vice President
$161k
2,945 shares
-100%
8Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$529k
7,821 shares
-8%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Catherine Corrigan sold $329k of EXPO | InsiderTell